Aspara K


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 53.8%
Glomerulonephritis Membranous 11.5%
Breast Cancer 7.7%
Drug Use For Unknown Indication 3.8%
Immunosuppressant Drug Therapy 3.2%
Febrile Neutropenia 2.6%
Glaucoma 2.6%
Hypertension 1.9%
Infection Prophylaxis 1.9%
Cataract Operation 1.3%
Cord Blood Transplant Therapy 1.3%
Diabetes Mellitus 1.3%
Inflammation 1.3%
Pregnancy Induced Hypertension 1.3%
Urinary Tract Infection 1.3%
Analgesia 0.6%
Cardiovascular Disorder 0.6%
Cerebrovascular Accident Prophylaxis 0.6%
Depression 0.6%
Diarrhoea 0.6%
Bronchitis 16.0%
Interstitial Lung Disease 16.0%
Toxic Epidermal Necrolysis 12.0%
Anosmia 8.0%
Cholangitis Suppurative 8.0%
Hyperkalaemia 8.0%
Pneumothorax 8.0%
Gamma-glutamyltransferase Increased 4.0%
Ileus Paralytic 4.0%
Primary Hyperaldosteronism 4.0%
Renal Failure Neonatal 4.0%
Renal Tubular Disorder 4.0%
White Blood Cell Count Increased 4.0%
Concomitant
Drug Use For Unknown Indication 16.4%
Prophylaxis 14.8%
Hypertension 11.0%
Pulmonary Arterial Hypertension 7.4%
Hypokalaemia 6.1%
Pulmonary Hypertension 4.7%
Insomnia 4.3%
Cardiac Failure 3.5%
Constipation 3.4%
Gastritis 3.0%
Product Used For Unknown Indication 3.0%
Crohn's Disease 2.9%
Rheumatoid Arthritis 2.9%
Hepatitis C 2.7%
Glaucoma 2.6%
Electrolyte Substitution Therapy 2.4%
Immunosuppression 2.4%
Cancer Pain 2.4%
Diarrhoea 2.1%
Lupus Nephritis 1.9%
Platelet Count Decreased 9.9%
Hepatic Function Abnormal 6.6%
Hypokalaemia 6.6%
Rhabdomyolysis 6.6%
White Blood Cell Count Decreased 6.6%
Sepsis 5.9%
Vomiting 5.9%
Interstitial Lung Disease 5.3%
Pneumonia 5.3%
Hepatic Encephalopathy 4.6%
Somnolence 4.6%
Anaemia Neonatal 3.9%
Cardiac Failure 3.9%
Cerebral Infarction 3.9%
Melaena 3.9%
Breast Cancer Recurrent 3.3%
Intraocular Pressure Increased 3.3%
Pulmonary Haemorrhage 3.3%
Skin Ulcer 3.3%
Tremor 3.3%

Drug Data